Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,450
Employees9,450
Headquarters
Greenfield, Indiana
HeadquartersGreenfield, Indiana
Founded
1954
Founded1954
Employees
9,450
Employees9,450

ELAN Key Statistics

Market cap
9.96B
Market cap9.96B
Price-Earnings ratio
23.31
Price-Earnings ratio23.31
Dividend yield
Dividend yield
Average volume
5.45M
Average volume5.45M
High today
$20.60
High today$20.60
Low today
$20.04
Low today$20.04
Open price
$20.55
Open price$20.55
Volume
3.82M
Volume3.82M
52 Week high
$21.76
52 Week high$21.76
52 Week low
$8.02
52 Week low$8.02

ELAN News

TipRanks 3d
Elanco upgraded to Overweight from Neutral at JPMorgan

JPMorgan upgraded Elanco (ELAN) to Overweight from Neutral with a price target of $24, up from $18. The company is entering an “attractive innovation cycle,” th...

TipRanks 3d
Elanco Animal Health: Promising Growth Driven by Innovation and Market Dynamics

J.P. Morgan analyst Chris Schott upgraded the rating on Elanco Animal Health to a Buy today, setting a price target of $24.00. Elevate Your Investing Strategy:...

Simply Wall St 4d
Elanco Animal Health: Assessing Valuation After Recent Share Price Momentum

Elanco Animal Health (ELAN) has seen its shares climb steadily, gaining 12% over the past month and jumping by 40% in the past 3 months. Investors appear intere...

Elanco Animal Health: Assessing Valuation After Recent Share Price Momentum

Analyst ratings

67%

of 15 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

More ELAN News

Simply Wall St 6d
Elanco Animal Health Is Up 8.2% After FDA Strengthens Zenrelia Safety Labeling – Has the Bull Case Changed?

Elanco Animal Health recently announced that the FDA approved updates to the Zenrelia label, removing prior language about fatal vaccine-induced disease risks a...

Elanco Animal Health Is Up 8.2% After FDA Strengthens Zenrelia Safety Labeling – Has the Bull Case Changed?

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.